Vir Biotechnology, Inc.VIRNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank25
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P25
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$-391.78M+12.2%
2024$-446.35M+42.7%
2023$-778.78M-146.8%
2022$1.66B+3595.0%
2021$-47.59M+75.1%
2020$-190.94M-47.3%
2019$-129.63M-37.8%
2018$-94.10M-41.8%
2017$-66.38M-